"Mark Fisher, MD provides treatment for rheumatoid and other types of arthritis, psoriasis, osteoporosis, and more in Camden County, NJ. Call today to schedule!"

During the past decade, Mark Fisher Md, Facr, Llc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mark Fisher Md, Facr, Llc" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mark Fisher Md, Facr, Llc" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Mark Fisher Md, Facr, Llc" in a lesser frequency.

Most popular intervention types in "Mark Fisher Md, Facr, Llc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mark Fisher Md, Facr, Llc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mark Fisher Md, Facr, Llc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mark Fisher Md, Facr, Llc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mark Fisher Md, Facr, Llc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".